comparemela.com

Latest Breaking News On - Christopherm chipman - Page 5 : comparemela.com

DGAP-News: Virpax(R) Pharmaceuticals Inc : Virpax Pharmaceuticals Announces Newly Issued Patent for Probudur(TM)

DGAP-News: Virpax(R) Pharmaceuticals Inc : Virpax Pharmaceuticals Announces Newly Issued Patent for Probudur(TM)
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Virpax Begins IND Enabling Studies of Envelta(TM)

Virpax Begins IND Enabling Studies of Envelta(TM)
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

DGAP-News: Virpax(R) Pharmaceuticals Inc : Virpax Begins IND Enabling Studies of Envelta(TM)

DGAP-News: Virpax(R) Pharmaceuticals Inc.: Virpax Begins IND Enabling Studies of Envelta(TM) vom 23.02.2021, 14:00 Uhr Bild: pixabay.com Virpax(R) Pharmaceuticals Inc.: Virpax Begins IND Enabling Studies of Envelta(TM) 23.02.2021 / 14:00 Virpax Begins IND Enabling Studies of Envelta(TM) WEST CHESTER, PA / ACCESSWIRE / February 23, 2021 / Virpax (R) Pharmaceuticals Inc. ( Virpax or the Company ) (NASDAQ:VRPX), today announced that according to the Cooperative Research and Development Agreement ( CRADA ) entered into between Virpax and the National Center for Advancing Translational Sciences ( NCATS ), an institute/center of the National Institutes of Health ( NIH ), U.S. Department of Health and Human Services, the NCATS has begun the Investigational New Drug ( IND ) enabling studies of Envelta(TM) for Virpax to support Virpax s future application for clearance from the FDA to initiate its first-in-human ( FIH ) clinical trials.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.